earli
recognit
rapid
initi
infect
control
precaut
import
strategi
control
sever
acut
respiratori
syndrom
sar
global
epidem
occur
march
june
approach
hamper
howev
fact
clinic
laboratori
featur
distinguish
patient
sar
respiratori
ill
reliabl
rapid
diagnost
test
current
gold
standard
laboratori
diagnosi
sar
coronaviru
cov
infect
antibodi
detect
indirect
immunofluoresc
assay
elisa
median
time
seroconvers
sar
patient
howev
day
onset
symptom
therefor
rapid
diagnosi
antibodi
detect
possibl
elisabas
antigen
detect
test
well
known
offer
high
specif
reproduc
lack
sensit
direct
detect
virus
cultur
viru
clinic
specimen
danger
insensit
detect
viral
rna
revers
transcriptionpcr
expens
laborintens
reli
avail
expertis
falseposit
result
may
result
contamin
addit
although
sarscov
detect
nasopharyng
specimen
sputum
stool
peak
viral
shed
site
therefor
optim
time
test
occur
around
day
ill
onset
decreas
issu
clinic
chemistri
report
kang
et
al
yip
et
al
present
evid
new
proteom
technolog
surfaceenhanc
laser
desorptionion
timeofflight
selditof
may
provid
solut
problem
selditof
proteom
technolog
involv
quantit
analysi
protein
mixtur
techniqu
use
trap
surfac
allow
differenti
captur
protein
base
intrins
properti
protein
yield
comprehens
profil
peptid
protein
biolog
fluid
without
need
first
carri
protein
separ
microlit
quantiti
sampl
appli
surfac
proteinbind
plate
physic
properti
bind
class
protein
bound
protein
laser
desorb
ioniz
mass
spectral
analysi
mass
protein
rang
small
peptid
da
protein
kda
calcul
base
time
flight
mixtur
protein
analyz
within
differ
sampl
uniqu
sampl
fingerprint
signatur
result
sampl
test
case
sar
infect
fingerprint
reflect
protein
specif
infecti
agent
well
protein
relat
host
respons
infecti
agent
kang
et
al
abl
show
selditof
sensit
specif
respect
diagnost
test
sar
abl
small
quantiti
serum
without
need
highlevel
biosafeti
facil
could
provid
result
within
h
initi
test
addit
import
find
test
posit
earli
cours
diseas
seven
sar
patient
test
within
h
onset
fever
posit
patient
could
group
accord
sever
diseas
abil
rapidli
diagnos
patient
could
allow
earli
implement
appropri
infect
control
measur
treatment
abl
predict
clinic
cours
ill
could
also
allow
optim
tailor
therapi
potent
toxic
agent
reserv
sever
diseas
yip
et
al
also
show
patient
infect
sar
uniqu
protein
profil
went
step
identifi
one
sar
protein
biomark
serum
amyloid
show
increas
concentr
correl
increas
sever
diseas
character
protein
make
selditof
profil
manner
provid
insight
pathophysiolog
diseas
may
also
lead
develop
direct
diagnost
tool
novel
therapeut
target
relev
sarscov
promis
selditof
appear
base
two
studi
limit
studi
worth
comment
exampl
kang
et
al
determin
sensit
specif
assay
compar
use
sar
patient
control
patient
control
includ
healthi
person
well
person
infect
although
import
use
healthi
patient
control
initi
valid
assay
diagnost
perspect
includ
type
control
calcul
sensit
specif
assay
may
artifici
enhanc
appar
sensit
specif
assay
infecti
diseas
perspect
one
tri
separ
healthi
patient
infect
ill
patient
rather
one
tri
identifi
caus
symptom
patient
present
similar
symptom
aid
select
appropri
therapi
specif
organ
addit
studi
patient
sar
well
character
term
time
specimen
collect
sever
diseas
case
control
patient
infect
sar
rais
question
whether
pattern
obtain
sar
patient
uniqu
sar
whether
similar
pattern
would
obtain
infecti
diseas
patient
match
sever
diseas
time
specimen
collect
report
yip
et
al
serum
amyloid
concentr
remain
increas
one
patient
superimpos
bacteri
infect
suggest
sever
bacteri
infect
could
give
increas
amyloid
sar
although
kang
et
al
yip
et
al
chose
appli
selditof
diagnosi
sar
mani
common
infecti
diseas
influenza
would
also
benefit
rapid
reliabl
diagnost
prognost
test
need
made
acut
expand
avail
therapeut
agent
infect
control
implic
mani
diseas
would
interest
determin
whether
selditof
reveal
profil
specif
prognost
common
infecti
diseas
profil
may
abl
use
develop
clinic
use
diagnost
algorithm
patient
present
cough
fever
pulmonari
infiltr
selditof
implement
clinic
laboratori
factor
includ
outlin
need
address
particular
expect
variat
profil
need
determin
healthi
person
without
infect
person
inflammatori
condit
without
infect
person
varieti
differ
infect
differ
time
period
cours
ill
addit
instrument
analyt
cost
avail
expertis
need
consid
notwithstand
limit
selditof
numer
potenti
applic
make
attract
emerg
technolog
theranost
new
field
link
rapid
diagnost
test
appropri
treatment
choic
respons
therapi
mean
optim
patient
care
selditof
field
proteom
clearli
meet
expect
newli
emerg
concept
selditof
aid
diagnosi
infect
caus
known
agent
also
potenti
aid
diagnosi
newli
emerg
infecti
diseas
etiolog
agent
known
addit
offer
insight
prognosi
provid
rapid
realtim
data
regard
respons
treatment
help
identifi
target
use
develop
specif
diagnost
test
specif
therapeut
clearli
selditof
field
proteom
emerg
technolog
potenti
posit
impact
field
infecti
diseas
encourag
studi
complet
area
